The global Molecular Diagnostics Market was valued at USD 6.12 billion in 2016 and is projected to reach USD 12.93 billion by 2025, growing at a CAGR of 8.67% from 2017 to 2025.
Molecular diagnostics is a combination of techniques used to analyze biological markers in the genome and proteome, genetic code and cells expression in terms of gene as proteinsâ€"by applying molecular biology to medical testing.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing oncology studies and cancer patients
1.2 Growing demand of personalized medicines
1.3 Growing Market of molecular biology and biomarker techniques in healthcare
1.4 Assured reimbursements
2. Market Restraints
2.1 Stringent regulations
Market Segmentation:
1. Global Molecular Diagnostics Market, by Technology:
1.1 Polymerase Chain Reaction (PCR)
1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Hybridization (In-Situ Hybridization & Fish)
1.4 DNA Sequencing and Next-Generation Sequencing
1.5 Microarray
1.6 Other Technologies
2. Global Molecular Diagnostics Market, by Application:
2.1 Infectious Diseases
2.1.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
2.1.2 Hepatitis B
2.1.3 Human Papillomavirus (HPV)
2.1.4 Human Immunodeficiency Virus (HIV)
2.1.5 Tuberculosis (TB)
2.1.6 Hepatitis C
2.1.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
2.1.8 Other Infectious Diseases
2.2 Oncology
2.2.1 Breast Cancer
2.2.2 Colorectal Cancer
2.2.3 Prostate Cancer
2.2.4 Other Cancers
2.3 Blood Screening
2.4 Genetic Tests
2.5 Microbiology
2.6 Other Applications
3. Global Molecular Diagnostics Market, by End User:
3.1 Hospital and Academic Laboratories
3.2 Reference Laboratories
3.3 Other End Users
4. Global Molecular Diagnostics Market, by Products and Services:
4.1 Reagents & Kits
4.2 Instruments
4.3 Software & Services
5. Global Molecular Diagnostics Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Abbott Laboratories
2. Qiagen N.V.
3. Roche Diagnostics
4. Hologic, Inc.
5. Grifols
6. Siemens Healthcare
7. Becton, Dickinson and Company
8. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
9. Biomérieux Sa
10. Cepheid Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Molecular Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL MOLECULAR DIAGNOSTICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global Molecular Diagnostics Market, by Technology:
5.1 Polymerase Chain Reaction (PCR)
5.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3 Hybridization (In-Situ Hybridization & Fish)
5.4 DNA Sequencing and Next-Generation Sequencing
5.5 Microarray
5.6 Other Technologies
6 Global Molecular Diagnostics Market, by Application:
6.1 Infectious Diseases
6.1.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.1.2 Hepatitis B
6.1.3 Human Papillomavirus (HPV)
6.1.4 Human Immunodeficiency Virus (HIV)
6.1.5 Tuberculosis (TB)
6.1.6 Hepatitis C
6.1.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.1.8 Other Infectious Diseases
6.2 Oncology
6.2.1 Breast Cancer
6.2.2 Colorectal Cancer
6.2.3 Prostate Cancer
6.2.4 Other Cancers
6.3 Blood Screening
6.4 Genetic Tests
6.5 Microbiology
6.6 Other Applications
7 Global Molecular Diagnostics Market, by End User:
7.1 Hospital and Academic Laboratories
7.2 Reference Laboratories
7.3 Other End Users
8 Global Molecular Diagnostics Market, by Products and Services:
8.1 Reagents & Kits
8.2 Instruments
8.3 Software & Services
9 GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
10 GLOBAL MOLECULAR DIAGNOSTICS MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Qiagen N.V.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Roche Diagnostics
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Hologic, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Grifols
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Siemens Healthcare
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Becton, Dickinson and Company
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Beckman Coulter Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Biomérieux Sa
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Cepheid Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Cloud-Based Molecular Modelling Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Molecular Modelling Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Molecular Modeling for Drug Development Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Molecular Interaction Analyzer Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The High Molecular Weight Hot Melt Polyester Resins Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitiv...
The High Molecular Weight Polyester Resin Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...